Abstract
Therapeutic drug monitoring (TDM) for type 2 diabetes medications like metformin is challenging due to the lack of rapid and sensitive methods. Standard assays are often inaccurate, time-consuming, and fail to capture real-time pharmacokinetic (PK) fluctuations. Here, we developed a portable organic electrochemical transistor (OECT) sensing system for continuous, real-time tracking of metformin levels. The laser-engraved OECT biosensor is functionalized with a specific Fe2O3 nanozyme on the gate electrode for electrocatalytic oxidation of metformin, enabling highly sensitive and selective detection. Seamless integration with a smartphone application and OECT system provides dynamic real-time metformin PK monitoring in vitro, fostering a pharmacologically informed approach to diabetes management. Our findings confirm the system's potential for home-care precision PK monitoring, paving the way for personalized diabetes care.
| Original language | English |
|---|---|
| Article number | 345833 |
| Journal | Analytica Chimica Acta |
| Volume | 1417 |
| DOIs | |
| State | Published - 1 Oct 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Electrochemical sensor
- Laser-induced graphene
- Metformin
- Organic electrochemical transistor
- Pharmacokinetic monitoring
Fingerprint
Dive into the research topics of 'Portable organic electrochemical transistor system for precision tracking of metformin pharmacokinetic profile'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver